Axelyf is a startup based in the United States, most recent round Pre-Seed.
Based in the United States, Axelyf is a startup. Its most recent tracked round is Pre-Seed.
Axelyf develops RNA therapeutics for oncology and autoimmune diseases using a proprietary lipid nanoparticle delivery platform to enable precise and potent drug delivery.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.